InvestorsObserver
×
News Home

Is Olema Pharmaceuticals Inc (OLMA) a Bad Choice in Biotechnology Thursday?

Thursday, November 30, 2023 01:49 PM | InvestorsObserver Analysts

Mentioned in this article

Is Olema Pharmaceuticals Inc (OLMA) a Bad Choice in Biotechnology Thursday?

A rating of 97 puts Olema Pharmaceuticals Inc (OLMA) near the top of the Biotechnology industry according to InvestorsObserver. Olema Pharmaceuticals Inc's score of 97 means it scores higher than 97% of stocks in the industry. Olema Pharmaceuticals Inc also received an overall rating of 83, putting it above 83% of all stocks. Biotechnology is ranked 48 out of the 148 industries.

Overall Score - 83
OLMA has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on OLMA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Olema Pharmaceuticals Inc Stock Today?

Olema Pharmaceuticals Inc (OLMA) stock has gained 6.11% while the S&P 500 is lower by -0.2% as of 1:47 PM on Thursday, Nov 30. OLMA is higher by $0.80 from the previous closing price of $13.18 on volume of 884,516 shares. Over the past year the S&P 500 is up 11.31% while OLMA is higher by 387.46%. OLMA lost -$2.32 per share the over the last 12 months. Click Here to get the full Stock Report for Olema Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App